Lexaria Bioscience Confirms More Than $2M Private Placement Deal

Lexaria Bioscience LXRP LXX sold more than 8.9 million shares of its common stock — including warrants to purchase up shares of common stock — in a private placement deal of over $2 million with a price per share of 23 cents. 

The transaction is expected to close on May 6.

The warrants issued of the shares are exercisable a price per share of 35 cents. 

The Special Equities Group, a division of Bradley Woods & Co., was the placement agent for the offering.

At closing, the British Columbia-based company will pay $154,199.90 and issue 658,087 warrants to BWC in connection with the investment of an additional 8,226,086 Shares with associated Warrants. Both Warrants have the same exercise terms and expiry date. 

The company plans to aim its founds gathered from the offering into the human pilot study researching the effectiveness of DehydraTECH tech related to enhancing the oral bioavailability of certain antiviral drugs of potential use against COVID-19 or other infectious disease states. 

Photo courtesy of Lexaria Bioscience

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsFinancingMarketslexaria bioscience
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.